Why I Bought the Dip in UnitedHealth Group

The market has abandoned UnitedHealth Group (NYSE: UNH), and that's exactly why I'm buying it. While investors flee the stock over rising medical costs and regulatory headlines, they're missing a crucial fact -- this is still the most dominant health insurer in America trading at recession-level valuations. At 11.5 times projected 2027 earnings, the pessimism looks overdone.The collapse has been breathtaking. Down 47.6% year to date as of this writing (Aug. 13, 2025) in a market hitting record highs, UnitedHealth faces real challenges: medical costs rising faster than premiums, a potential $1.6 billion settlement over billing practices, and regulatory scrutiny of its Optum unit. These aren't minor headwinds.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool